Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 41

Trial Status

Completed3
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT03656029Phase 2Completed
Dose-response of Cannabis and Driving
Abuse CannabisCognitive ImpairmentDriving Impaired
PrincipalinvestigatorStart date: 2021-06-04
NCT00370188Phase 2Withdrawn
Topiramate on Gambling-Related Behaviours
Gambling
Principalinvestigator
NCT00427206Phase 4Completed
Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing
Alcohol Related Disorders
Principalinvestigator
NCT02710578Not ApplicableCompleted
Alcohol Effects on Driving-related Skills of Young Drivers
Psychomotor Impairment
Principalinvestigator

Research Network

Collaboration Network

4 collaborators·4 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Bernard Le Foll, MD, PhD

Centre for Addiction and Mental Health

Related
13 trials

Shared therapeutic areas:

Psychomotor Impairment

Worked with same sponsors:

Centre for Addiction and Mental HealthOntario Ministry of Transportation
Collaborated on 1 trial
Similarity Score14%

Richard C Dart, MD, PhD

Denver Health/Rocky Mountain Poison & Drug Center

Related
2 trials

Shared therapeutic areas:

Alcohol-Related Disorders

Worked with same sponsors:

Denver Health and Hospital AuthorityMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Collaborated on 1 trial
Similarity Score14%

Robert Mann, PhD

Centre for Addiction and Mental Health

Related
1 trials

Shared therapeutic areas:

Psychomotor Impairment

Worked with same sponsors:

Centre for Addiction and Mental HealthOntario Ministry of Transportation
Collaborated on 1 trial
Similarity Score14%

Selami Varol Ăœlker, Phd

ĂœskĂ¼dar University

Related
7 trials

Shared therapeutic areas:

Alcohol-Related DisordersCognitive Dysfunction
Similarity Score10%

Metin ÇınaroÄŸlu, Phd

Istanbul Nisantasi University

Related
9 trials

Shared therapeutic areas:

Alcohol-Related DisordersCognitive Dysfunction
Similarity Score10%

Nicolai Goettel, MD

University Hospital, Basel, Switzerland

Related
8 trials

Shared therapeutic areas:

Cognitive Dysfunction
Similarity Score5%

Olivier Beauchet, MD

Jewish General Hospital

Related
19 trials

Shared therapeutic areas:

Cognitive Dysfunction
Similarity Score5%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

Related
74 trials

Shared therapeutic areas:

Cognitive Dysfunction
Similarity Score5%

Vijay A Ramchandani, Ph.D.

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Related
9 trials

Shared therapeutic areas:

Alcohol-Related Disorders
Similarity Score5%

Ebru Calik Kutukcu, PhD

Hacettepe University

Related
11 trials

Shared therapeutic areas:

Cognitive Dysfunction
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT03656029Phase 2PrincipalInvestigator

Dose-response of Cannabis and Driving

Abuse CannabisCognitive ImpairmentDriving Impaired
Completed
NCT00370188Phase 2PrincipalInvestigator

Topiramate on Gambling-Related Behaviours

Gambling
Withdrawn
NCT00427206Phase 4PrincipalInvestigator

Hepatic Function in Alcoholics Following 5 Days of Acetaminophen Dosing

Alcohol Related Disorders
Completed
NCT02710578Not ApplicablePrincipalInvestigator

Alcohol Effects on Driving-related Skills of Young Drivers

Psychomotor Impairment
Completed

All 4 trials loaded